Latest News and Press Releases

TORONTO and CALGARY, Alberta and MONTREAL, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Rogers Communications Inc., Shaw Communications Inc., the Shaw Family Living Trust, and Quebecor Inc. today announced an...

ALISO VIEJO, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Sounding Board, the first unified Leader Development Platform designed to bridge the leadership gap, has announced the availability of its...

PETAH TIKVA, Israel and TYSONS CORNER, Va. and COLORADO SPRINGS, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions...

Not for Distribution to U.S. Newswire Services or Dissemination in the United States VANCOUVER, British Columbia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Regulus Resources Inc. ("Regulus" or the...

Indian Land, S.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Sharonview Federal Credit Union, one of the nation’s top 200 credit unions, is proud to announce that Bryan Lockman has taken on the role of Vice...

WATERTOWN, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science...

CHATHAM, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it has...

MISSISSAUGA, Ontario, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is...

•  AML Patients Receive Tuspetinib Monotherapy to Kick Off APTIVATE Phase 1/2 Trial•  New Response Emerges with 40 mg Tuspetinib in FLT3 Wildtype AML Patient•  Aptose Elucidates Rationale for...

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric...